Chen, Y., Tsai, M., Lee, M., Kuo, C., Shen, M., Tsai, Y., . . . Yang, C. (2021). Lower starting dose of afatinib for the treatment of metastatic lung adenocarcinoma harboring exon 21 and exon 19 mutations. BMC Cancer.
Chicago Stili AlıntıChen, Yi-Chieh, et al. "Lower Starting Dose of Afatinib for the Treatment of Metastatic Lung Adenocarcinoma Harboring Exon 21 and Exon 19 Mutations." BMC Cancer 2021.
MLA AlıntıChen, Yi-Chieh, et al. "Lower Starting Dose of Afatinib for the Treatment of Metastatic Lung Adenocarcinoma Harboring Exon 21 and Exon 19 Mutations." BMC Cancer 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..